Navigation Links
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
Date:5/14/2013

f $7.2 million for the quarter ended March 31, 2013, compared to a net loss of $2.2 million for the quarter ended March 31, 2012.  The quarter ended March 31, 2013, included non-cash charges of $1.8 million from the change in value of the amended and restated convertible promissory note originally issued to GlaxoSmithKline in 2010, which was attributable to increases in value of the underlying common stock of the Company since December 31, 2012.  Basic and diluted net loss per share was $0.20 for the quarter ended March 31, 2013, compared to net loss per share of $13.06 for the quarter ended March 31, 2012. The comparison of net loss per share for the periods presented is impacted by the initial public offering and concurrent common stock issuances in October 2012.

Regulus recognized revenue of $3.2 million for the quarter ended March 31, 2013, compared to $3.3 million for the quarter ended March 31, 2012.  Revenue during these periods consisted primarily of amortization of up-front payments received from our strategic alliances and collaborations, which is recognized over the estimated period of performance.

Research and development expenses were $6.9 million for the quarter ended March 31, 2013, compared to $4.6 million for the quarter ended March 31, 2012.  The increase is attributable to an expansion of our research and development team, expertise and capabilities, in addition to increasing pre-clinical study activities in the first quarter of 2013, compared to the same period in 2012.

General and administrative expenses were $1.9 million for the quarter ended March 31, 2013, compared to $0.9 million for the quarter ended March 31, 2012.  The increase is attributable to costs associated with increases related to additional personnel required to support the growth of the business, in addition to an increase in overall operating costs associated with being an SEC registrant in the first quarter of 2013, compared to the
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
2. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
3. Regulus to Present at Future Leaders in the Biotech Industry Conference
4. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
5. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
6. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
7. Regulus to Present at Two Upcoming Investor Conferences
8. Regulus Appoints Mark G. Foletta to its Board of Directors
9. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
10. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
11. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/31/2015)... , July 31, 2015 ... solutions for video, data and cloud computing operators ... a leading pharma giant for Internet of Things ... IoT applications offered on subscription model. ... Pharma giant is striving for business innovations to ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... WARSAW, Ind., April 12, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
... April 12, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical ... or the "Company"), a developer, manufacturer and distributor ... ("TCM") in China, today announced that its wholly ... has received official approval to produce water-based mixtures. ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3
(Date:7/31/2015)... ... 31, 2015 , ... A family-run business in Grand Rapids, ... sourced all over the world, then manufactured into specific formulations in northern Michigan. ... highest-quality oils in the industry, which we are bringing to consumers at prices ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Super-Sod wants to ... a Super-Sod Pro Page as the perfect fit for such a goal. ... and articles. The social website is a dynamic site that spreads home and home ...
(Date:7/31/2015)... ... ... India Network Foundation sponsors visitor health insurance program for all non-US ... past 25 years. As India Network offers coverage for all age groups, many elderly ... their children and grand children. India Network specializes in covering pre-existing conditions when ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the recent ... of individuals who remain undiagnosed, treatment options for patients are becoming more prevalent ... CPAP therapy due to its overall lack of comfort and highly invasive nature, ...
(Date:7/30/2015)... ... ... The Venetian on Grace Bay in the Turks & Caicos Islands is pleased to announce ... 40% on their stay while enjoying some of the most beautiful ocean views in the ... a chance to reconnect with loved ones and rediscover one's best self. The sea ...
Breaking Medicine News(10 mins):Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2
... from nagging tinnitus can benefit from internet-based therapy just ... therapy sessions. These are the findings of a German-Swedish ... tried out various forms of therapy over a ten-week ... group therapy sessions was significantly better than that of ...
... March 7 (HealthDay News) -- Exposure to cocaine, tobacco ... score lower on academic tests, according to a new ... with no signs of fetal alcohol syndrome, was associated ... and spelling, Boston University researchers found. The negative ...
... TUESDAY, March 6 (HealthDay News) -- Most stroke patients undergo ... contributes to the rising costs of stroke care in the ... researchers analyzed data from more than 600,000 patients diagnosed with ... that 95 percent of the patients who had MRI scans ...
... 6 (HealthDay News) -- A smoking ban in Scotland ... a new study finds. The nationwide ban on smoking ... analyzed data on preterm delivery and small-for-gestational-age babies born between ... who smoked dropped from more than 25 percent before the ...
... When faced with stressful situations, older adults who sleep poorly ... new study finds. The marker, called interleukin-6 (IL-6), has ... cardiovascular disease, diabetes and psychiatric problems. "Our study suggests ... and what poor sleep may be doing to our physiological ...
... and has many ways of evading the drugs used by oncologists ... , Now, ... advanced form of melanoma gets around an inhibitor, Zelboraf, which targets ... of the melanoma genome that encodes proteins, called the exome, Jonsson ...
Cached Medicine News:Health News:Internet-based therapy relieves persistent tinnitus 2Health News:Fetal Cocaine Exposure May Not Affect Kids' Academics: Study 2Health News:Brain Scans Overused on U.S. Stroke Patients, Study Says 2Health News:Poor Sleep May Impact Stress Response in Older Adults 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 3
Hypervisor III Central Monitoring System...
For the critical care environment, telemetry, emergency room and other monitoring areas....
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... is a solution for hospitals, communicating ... signs monitoring. Waveform and numeric data ... simultaneous display of up to 32 ... trends are stored automatically. Alarms provide ...
Medicine Products: